Tue. 12 Mar 2024, 4:17pm ET
Benzinga
Earnings, Earnings Beats, News
Clearside Biomedical (NASDAQ:CLSD) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.09) by 11.11 percent. The company reported quarterly sales of $6.30 million which beat the analyst consensus estimate of $4.43 million by 42.11 percent. This is a 1.81K percent increase over sales of $330.00 thousand the same period last year.